Opioids are taken through a wide range of routes, from swallowing a pill to wearing a skin patch to receiving an injection. The method matters because it directly affects how quickly the drug reaches the brain, how long it lasts, and how intense its effects are. Most prescribed opioids are taken by mouth, but clinicians choose among roughly a dozen delivery routes depending on the type of pain, how urgently relief is needed, and whether a patient can swallow.
Oral: The Most Common Route
The majority of prescription opioids are designed to be swallowed. Codeine, hydrocodone, oxycodone, tramadol, and tapentadol are all oral-only medications. Morphine, hydromorphone, oxymorphone, and methadone can be given other ways in a hospital, but outside of one, they’re usually taken as tablets or liquid.
When you swallow an opioid, it travels through your digestive tract and gets partially broken down by the liver before reaching your bloodstream. This process, called first-pass metabolism, significantly reduces the amount of active drug that actually makes it into circulation. Oral morphine, for example, has a bioavailability of roughly 24% in people who haven’t taken opioids before, meaning about three-quarters of the dose is lost before it can take effect. In people with long-term opioid exposure, that number climbs to around 37%. Peak blood levels after an oral dose typically arrive within 20 to 36 minutes.
This slower, less efficient absorption is actually a clinical advantage for managing steady, ongoing pain. It produces a more gradual rise in drug levels, which means less of the sharp spike that drives euphoria and addiction risk.
Immediate-Release vs. Extended-Release Formulations
Oral opioids come in two basic designs. Immediate-release tablets dissolve normally in the stomach and deliver their full dose relatively quickly. CDC guidelines recommend these for acute pain, at the lowest effective dose and for the shortest duration necessary.
Extended-release formulations use clever engineering to slow things down. Some tablets contain a mix of water-attracting and water-repelling polymers. When stomach fluid reaches the tablet, it forms a gel layer on the surface. The opioid can only escape by slowly diffusing through that gel, stretching a single dose across 8 to 24 hours. Other formulations use capsules filled with tiny coated pellets. The coating dissolves gradually as the pellets move from the acidic stomach into the more alkaline intestine, progressively opening more pores and releasing drug along the way.
These extended-release designs rely on their physical structure to control dosing. Crushing, chewing, or breaking the tablet destroys that structure and releases the entire dose at once. This “dose dumping” can produce dangerously high blood levels in minutes. Even well-meaning patients who split a tablet for easier swallowing can accidentally disrupt the release mechanism. This is why extended-release opioid labels carry strong warnings against altering the tablet in any way.
Through the Skin: Transdermal Patches
Fentanyl and buprenorphine are both available as adhesive patches worn on the skin. The drug passes through the skin at a controlled rate, entering the bloodstream without involving the digestive system at all.
Fentanyl patches are the most widely used version. The amount delivered depends on the patch’s surface area, with larger patches releasing more drug per hour. After you apply a patch, it takes anywhere from 1 to 40 hours to reach a minimally effective blood level, and 12 to 48 hours to hit peak concentration. Steady, consistent drug levels are reached by the third day of use, as long as you replace the patch on schedule (typically every 72 hours).
One important quirk of transdermal delivery: the skin acts as a reservoir. Even after you remove a patch, fentanyl continues absorbing from the drug stored in the skin layers. The drug’s effective half-life with patches is 13 to 25 hours, meaning it takes a full day or more for levels to drop meaningfully after removal. This reservoir effect is important to understand because it means side effects or overdose symptoms won’t resolve immediately just because the patch comes off.
Under the Tongue and Inside the Cheek
Sublingual (under the tongue) and buccal (inside the cheek) delivery takes advantage of the thin, blood-vessel-rich membranes in your mouth. Drugs absorbed here enter the bloodstream directly, bypassing the liver’s first-pass metabolism entirely. This means lower doses can achieve the same therapeutic effect compared to swallowing the same drug.
Buprenorphine, widely used in opioid use disorder treatment, is most commonly given as a sublingual tablet or film. You place it under the tongue and let it dissolve without swallowing. Fentanyl is also available in sublingual tablets and buccal films for breakthrough cancer pain, where rapid onset matters.
These routes produce faster absorption than swallowing a pill but are simpler and less invasive than an injection, making them practical for both clinical settings and home use.
Intranasal Delivery
Some opioids and opioid-related drugs are delivered as nasal sprays. The nasal lining is thin and richly supplied with blood vessels, so drugs sprayed into the nose reach the bloodstream quickly, bypass liver metabolism, and require relatively low doses to be effective.
Fentanyl and butorphanol are both available in prescription nasal spray form. On the emergency side, naloxone (the opioid overdose reversal agent) is widely distributed as a nasal spray specifically because it’s fast and requires no medical training to use. Intranasal naloxone produces a more rapid response than an intramuscular injection, with 83% of overdose patients responding at an average time of 3.4 minutes. This speed, combined with the simplicity of spraying into someone’s nose, has made it a critical tool for bystander overdose response.
Injection Routes
Injected opioids bypass the digestive system entirely, delivering drug straight into the bloodstream or nearby tissue. This makes them the fastest-acting option and the standard in hospitals for severe acute pain.
Intravenous (IV) injection delivers the drug directly into a vein, producing almost immediate effects. It’s the route used for post-surgical pain, severe trauma, and emergency settings. Morphine, fentanyl, hydromorphone, and methadone can all be given this way. Intramuscular (IM) injection places the drug into muscle tissue, where it absorbs over minutes. Subcutaneous injection delivers it just under the skin, with a slightly slower absorption rate than IM. These alternatives are used when IV access isn’t available or when a somewhat slower onset is acceptable.
Outside of medical settings, injection is also the route most associated with illicit opioid use. IV injection produces the highest peak blood concentration in the shortest time, which drives intense euphoria but also carries the greatest overdose risk and exposes users to infections, vein damage, and bloodborne diseases.
Rectal Administration
Morphine, hydromorphone, and oxymorphone are all available in rectal suppository form. This route is used primarily in palliative care, when a patient can no longer swallow due to nausea, vomiting, difficulty with consciousness, or obstruction. The rectum’s lining absorbs drugs into the bloodstream with partial bypass of liver metabolism, making it a practical alternative when the oral route is no longer an option. It requires no needles and can be administered by a caregiver at home.
Spinal Delivery for Severe Pain
For pain that doesn’t respond to any of the routes above, opioids can be delivered directly to the spinal cord through epidural or intrathecal injection. Epidural delivery places the drug just outside the membrane surrounding the spinal cord. Intrathecal delivery goes one step further, injecting it directly into the fluid that bathes the spinal cord itself.
Because the drug reaches pain-signaling nerves with almost no dilution, spinal delivery requires dramatically smaller doses than oral or IV administration to achieve the same relief. It’s reserved for specific situations: intractable cancer pain that hasn’t responded to standard treatment, chronic conditions like failed back syndrome or complex regional pain syndrome, or end-of-life care where time is too limited to titrate other routes. Some patients receive spinal opioids through implanted pumps that deliver a continuous micro-dose over weeks or months.
Why the Route Matters
The way an opioid enters your body shapes nearly everything about the experience. Faster routes (IV, intranasal) produce higher peak levels more quickly, which means faster relief but also greater risk of respiratory depression and a stronger pull toward dependence. Slower routes (oral extended-release, transdermal) produce flatter, more sustained drug levels that are better suited to chronic pain but take longer to provide relief.
Prescribers match the route to the clinical need. Acute surgical pain calls for IV delivery in the hospital, transitioning to oral immediate-release at home. Chronic cancer pain might start with oral medications and shift to a fentanyl patch for steady around-the-clock coverage, with sublingual fentanyl available for breakthrough episodes. Palliative care may require rectal or spinal routes as the disease progresses. Each route is a tool chosen for a specific purpose, balancing speed, convenience, duration, and safety.